CryoLife Says SEC Inquiry Tied to Recall

CryoLife Inc., which processes human tissue for transplant, said it is under investigation by the Securities and Exchange Commission after a sweeping federal recall of the company’s tissues last week.

CryoLife, based in Atlanta, said the SEC has requested information on its accounting practices and trading in company shares in the last 11 months, a period in which health officials are investigating how the company handled tissue.

Its shares, which were halted before the news, rose 6 cents to $3.05 on the New York Stock Exchange.